Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A substudy of the RISK-PCI trial

Heart and Vessels

Volumn 28, Issue 4, 2013, Pages 424-433

  Mrdovic, Igor ^a,b   Savic, Lidija ^b   Lasica, Ratko ^b   Krljanac, Gordana ^b   Asanin, Milika ^a,b   Brdar, Natasa ^b   Djuricic, Nemanja ^b   Cvetinovic, Natasa ^b   Marinkovic, Jelena ^a   Perunicic, Jovan ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Primary percutaneous coronary intervention; Risk score; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PANTOPRAZOLE; RANITIDINE; TIROFIBAN;

ADULT; ADVERSE OUTCOME; AGED; ALGORITHM; ARTICLE; BLEEDING; BOOTSTRAPPING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHI SQUARE TEST; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK PCI SCORE; SENSITIVITY ANALYSIS; STENT THROMBOSIS;

AGED; AREA UNDER CURVE; CHI-SQUARE DISTRIBUTION; CORONARY THROMBOSIS; DECISION SUPPORT TECHNIQUES; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SERBIA; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84880288267     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-012-0276-z     Document Type: Article

References (36)

1. Raber L, Windecker S (2011) Primary percutaneous coronary intervention and risk of stent thrombosis. A look beyond the HORIZON. Circulation 123:1709-1712
2. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ, for the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators (2002) Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346:957-966
3. Horii M, Uemura S, Uemura M, Matsumoto M, Ishizashi H, Imagawa K, Iwama H, Takeda Y, Kawata H, Nakajima T, Fujimura Y, Saito Y (2008) Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation. Heart Vessels 23:301-307
4. Sianos G, Papafaklis MI, Daemen J, Vaina S, van Mieghem CA, van Domburg RT, Michalis LK, Serruys PW (2007) Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction. The importance of thrombus burden. J Am Coll Cardiol 50:573-583
5. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R (2008) Delayed arterial healing and increased late stent thrombosis at culprit sites after drug eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 118:1138-1145
6. Lagerqvist B, Carlsson J, Frobert O, Lindback J, Schersten F, Stenestrand U, James SK (2007) Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry. Circ Cardiovasc Interv 2:401-8
7. Bavry AA, Bhatt DL (2007) Drug-eluting stents. Dual antiplatelet therapy for every survivor? Circulation 116:696-699
8. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators, Freij A, Thorsén M; the PLATO investigators (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045-1057
9. Aoki J, Lansky AJ, Mehran R, Moses J, Bertrand ME, McLaurin BT, Cox DA, Lincoff AM, Ohman EM, White HD, Parise H, Leon MB, Stone GW (2009) Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare-metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circulation 119:687-698
10. Airoldi F, Colombo A, Morici N, Latib A, Cosgrave J, Buellesfeld L, Bonizzoni E, Carlino M, Gerckens U, Godino C, Melzi G, Michev I, Montorfano M, Sangiorgi GM, Qasim A, Chieffo A, Briguori C, Grube E (2007) Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation 116:745-754
11. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126-2130
12. Schuhlen H, Kastrati A, Dirschinger J, Hausleiter J, Elezi S, Wehinger A, Pache J, Hadamitzky M, Schomig A (1998) Intracoronary stenting and risk for major adverse cardiac events during the first month. Circulation 98:104-111
13. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB (2005) Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45:995-998
14. Mrdovic I, Savic L, Perunicic J, Asanin M, Lasica R, Marinkovic J, Vasiljevic Z, Ostojic (2009) Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel. Rationale and design of the RISK-PCI study. J Interv Cardiol 22:320-328
15. Mrdovic I, Savic L, Krljanac G, Perunicic J, Asanin M, Lasica R, Marinkovic J, Vasiljevic Z, Ostojic M (2011) Predicting 30-day Major Adverse Cardiovascular Events After Primary Percutaneous Coronary Intervention. The RISK-PCI score. Int J Cardiol. doi: 10.1016/J.ijcard.2011.05.071
16. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344-2351
17. Honda Y, Fitzgerald PJ (2003) Stent thrombosis: an issue revisited in a changing world. Circulation 108:2-5
18. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice. Lancet 369:667-678
19. Wenaweser P, Rey C, Eberli FR, Togni M, Tuller D, Locher S, Remondino A, Seiler C, Hess OM, Meier B, Windecker S (2005) Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J 26:1180-1187
20. Tolleson TR, Newby LK, Harrington RA, Bhapkar MV, Verheugt FWA, Berger PB, Moliterno DJ, White HD, Ohman EM, van de Werf F, Topol EJ, Califf RM, for the SYMPHONY and the 2nd SYMPHONY Investigators (2003) Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials). Am J Cardiol 92:330-333
21. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM, for the TRITON-TIMI 38 Investigators (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001-2015
22. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrie D, Slama MS, Merkely B, Erglis A, Margheri M, Varenne O, Cebrian A, Stoll HP, Snead DB, Bode C (2006) Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355:1093-1104
23. Dangas GD, Caixeta A, Mehran R, Parise H, Lansky AL, Cristea E, Brodie BR, Witzenbichler B, Guagliumi G, Peruga JZ, Dudek D, Moeckel M, Stone GW, for the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial Investigators (2011) Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation 123:1745-1756
24. Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Pittl U, Syvanne M, Suttorp MJ, Violini R, Schomig A (2007) Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 28:2706-2713
25. Mehta RH, Ou FS, Peterson ED, Shaw RE, Hillegass Jr WB, Rumsfeld JS, Roe MT, for the American College of Cardiology-National Cardiovascular Database Registry Investigators (2009) Cinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention. JACC Cardiovasc Interv 2:56-64
26. Mariani M, Fetiveau R, Rosseti E, Poli A, Poletti F, Vandoni P, D'Urbano M, Cafiero F, Mariani G, Klersy C, De Servi S (2006) Significance of total and differential leukocyte count in patients with acute myocardial infarction treated with primary coronary angioplasty. Eur Heart J 27:2511-2515
27. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, Kim SW, Bui A, Gevorkian N, Xue Z, Smith K, Fournadjieva J, Suddath WO, Satler LF, Pichard AD, Kent KM, Waksman R (2006) Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113:1108-1113
28. Ferrari E, Benhamou M, Cerboni P, Marcel B (2005) Coronary syndromes following aspirin withdrawal. J Am Coll Cardiol 45:456-459
29. Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW, Hong MK, Kim JJ, Park SJ (2006) Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 98:352-356
30. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ (2006) Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement. Circulation 113:2803-2809
31. Mauri L, Hsieh W, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE (2007) Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356:1020-1029
32. Wenaweser P, Dörffler-Melly J, Imboden K, Windecker S, Togni M, Meier B, Haeberli A, Hess OM (2005) Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 45:1748-1752
33. Moussa I, Di Mario C, Reimers B, Akiyama T, Tobis J, Colombo A (1997) Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome. J Am Coll Cardiol 29:6-12
34. Muraoka Y, Sonoda S, Tsuda Y, Tanaka S, Okazaki M, Otsuji Y (2011) Effect of intravascular ultrasound-guided adjuvant high-pressure non-compliant balloon post-dilation after drug-eluting stent implantation. Heart Vessels 26:565-571
35. Tanaka N, Pijls NHJ, Koolen JJ, Botman KJ, Michels HR, Brueren BRG, Peels K, Shindo N, Yamashita Y, Yamashina A (2011) Assessment of optimum stent deployment by stent boost imaging: comparison with intravascular ultrasound. Heart Vessels. doi: 10.1007/s00380-011-0202-9
36. Boden H, van der Hoeven BL, Liem SS, Atary JZ, Cannegieter SC, Atsma DE, Bootsma M, Jukema JW, Zeppenfeld K, Oemrawsingh PV, van der Wall EE, Schalij MJ (2012) Five-year clinical follow-up from the MISSION intervention study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial. EuroIntervention 7:1021-1029